Cargando…

Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq

BACKGROUND: Invasive urothelial carcinoma (iUC) is a major cause of death in humans, and approximately 165,000 individuals succumb to this cancer annually worldwide. Comparative oncology using relevant animal models is necessary to improve our understanding of progression, diagnosis, and treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Shingo, Tomiyasu, Hirotaka, Tsuboi, Masaya, Inoue, Akiko, Ishihara, Genki, Uchikai, Takao, Chambers, James K., Uchida, Kazuyuki, Yonezawa, Tomohiro, Matsuki, Naoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921755/
https://www.ncbi.nlm.nih.gov/pubmed/29699519
http://dx.doi.org/10.1186/s12885-018-4409-3
_version_ 1783318080456228864
author Maeda, Shingo
Tomiyasu, Hirotaka
Tsuboi, Masaya
Inoue, Akiko
Ishihara, Genki
Uchikai, Takao
Chambers, James K.
Uchida, Kazuyuki
Yonezawa, Tomohiro
Matsuki, Naoaki
author_facet Maeda, Shingo
Tomiyasu, Hirotaka
Tsuboi, Masaya
Inoue, Akiko
Ishihara, Genki
Uchikai, Takao
Chambers, James K.
Uchida, Kazuyuki
Yonezawa, Tomohiro
Matsuki, Naoaki
author_sort Maeda, Shingo
collection PubMed
description BACKGROUND: Invasive urothelial carcinoma (iUC) is a major cause of death in humans, and approximately 165,000 individuals succumb to this cancer annually worldwide. Comparative oncology using relevant animal models is necessary to improve our understanding of progression, diagnosis, and treatment of iUC. Companion canines are a preferred animal model of iUC due to spontaneous tumor development and similarity to human disease in terms of histopathology, metastatic behavior, and treatment response. However, the comprehensive molecular characterization of canine iUC is not well documented. In this study, we performed transcriptome analysis of tissue samples from canine iUC and normal bladders using an RNA sequencing (RNA-Seq) approach to identify key molecular pathways in canine iUC. METHODS: Total RNA was extracted from bladder tissues of 11 dogs with iUC and five healthy dogs, and RNA-Seq was conducted. Ingenuity Pathway Analysis (IPA) was used to assign differentially expressed genes to known upstream regulators and functional networks. RESULTS: Differential gene expression analysis of the RNA-Seq data revealed 2531 differentially expressed genes, comprising 1007 upregulated and 1524 downregulated genes, in canine iUC. IPA revealed that the most activated upstream regulator was PTGER2 (encoding the prostaglandin E(2) receptor EP2), which is consistent with the therapeutic efficiency of cyclooxygenase inhibitors in canine iUC. Similar to human iUC, canine iUC exhibited upregulated ERBB2 and downregulated TP53 pathways. Biological functions associated with cancer, cell proliferation, and leukocyte migration were predicted to be activated, while muscle functions were predicted to be inhibited, indicating muscle-invasive tumor property. CONCLUSIONS: Our data confirmed similarities in gene expression patterns between canine and human iUC and identified potential therapeutic targets (PTGER2, ERBB2, CCND1, Vegf, and EGFR), suggesting the value of naturally occurring canine iUC as a relevant animal model for human iUC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4409-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5921755
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59217552018-05-01 Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq Maeda, Shingo Tomiyasu, Hirotaka Tsuboi, Masaya Inoue, Akiko Ishihara, Genki Uchikai, Takao Chambers, James K. Uchida, Kazuyuki Yonezawa, Tomohiro Matsuki, Naoaki BMC Cancer Research Article BACKGROUND: Invasive urothelial carcinoma (iUC) is a major cause of death in humans, and approximately 165,000 individuals succumb to this cancer annually worldwide. Comparative oncology using relevant animal models is necessary to improve our understanding of progression, diagnosis, and treatment of iUC. Companion canines are a preferred animal model of iUC due to spontaneous tumor development and similarity to human disease in terms of histopathology, metastatic behavior, and treatment response. However, the comprehensive molecular characterization of canine iUC is not well documented. In this study, we performed transcriptome analysis of tissue samples from canine iUC and normal bladders using an RNA sequencing (RNA-Seq) approach to identify key molecular pathways in canine iUC. METHODS: Total RNA was extracted from bladder tissues of 11 dogs with iUC and five healthy dogs, and RNA-Seq was conducted. Ingenuity Pathway Analysis (IPA) was used to assign differentially expressed genes to known upstream regulators and functional networks. RESULTS: Differential gene expression analysis of the RNA-Seq data revealed 2531 differentially expressed genes, comprising 1007 upregulated and 1524 downregulated genes, in canine iUC. IPA revealed that the most activated upstream regulator was PTGER2 (encoding the prostaglandin E(2) receptor EP2), which is consistent with the therapeutic efficiency of cyclooxygenase inhibitors in canine iUC. Similar to human iUC, canine iUC exhibited upregulated ERBB2 and downregulated TP53 pathways. Biological functions associated with cancer, cell proliferation, and leukocyte migration were predicted to be activated, while muscle functions were predicted to be inhibited, indicating muscle-invasive tumor property. CONCLUSIONS: Our data confirmed similarities in gene expression patterns between canine and human iUC and identified potential therapeutic targets (PTGER2, ERBB2, CCND1, Vegf, and EGFR), suggesting the value of naturally occurring canine iUC as a relevant animal model for human iUC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4409-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-27 /pmc/articles/PMC5921755/ /pubmed/29699519 http://dx.doi.org/10.1186/s12885-018-4409-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Maeda, Shingo
Tomiyasu, Hirotaka
Tsuboi, Masaya
Inoue, Akiko
Ishihara, Genki
Uchikai, Takao
Chambers, James K.
Uchida, Kazuyuki
Yonezawa, Tomohiro
Matsuki, Naoaki
Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
title Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
title_full Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
title_fullStr Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
title_full_unstemmed Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
title_short Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
title_sort comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by rna-seq
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921755/
https://www.ncbi.nlm.nih.gov/pubmed/29699519
http://dx.doi.org/10.1186/s12885-018-4409-3
work_keys_str_mv AT maedashingo comprehensivegeneexpressionanalysisofcanineinvasiveurothelialbladdercarcinomabyrnaseq
AT tomiyasuhirotaka comprehensivegeneexpressionanalysisofcanineinvasiveurothelialbladdercarcinomabyrnaseq
AT tsuboimasaya comprehensivegeneexpressionanalysisofcanineinvasiveurothelialbladdercarcinomabyrnaseq
AT inoueakiko comprehensivegeneexpressionanalysisofcanineinvasiveurothelialbladdercarcinomabyrnaseq
AT ishiharagenki comprehensivegeneexpressionanalysisofcanineinvasiveurothelialbladdercarcinomabyrnaseq
AT uchikaitakao comprehensivegeneexpressionanalysisofcanineinvasiveurothelialbladdercarcinomabyrnaseq
AT chambersjamesk comprehensivegeneexpressionanalysisofcanineinvasiveurothelialbladdercarcinomabyrnaseq
AT uchidakazuyuki comprehensivegeneexpressionanalysisofcanineinvasiveurothelialbladdercarcinomabyrnaseq
AT yonezawatomohiro comprehensivegeneexpressionanalysisofcanineinvasiveurothelialbladdercarcinomabyrnaseq
AT matsukinaoaki comprehensivegeneexpressionanalysisofcanineinvasiveurothelialbladdercarcinomabyrnaseq